239 related articles for article (PubMed ID: 17464135)
1. Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit.
Davenport A
Contrib Nephrol; 2007; 156():259-66. PubMed ID: 17464135
[TBL] [Abstract][Full Text] [Related]
2. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Warkentin TE; Greinacher A
Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
[TBL] [Abstract][Full Text] [Related]
4. New treatment options for heparin-induced thrombocytopenia.
Ortel TL; Chong BH
Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
[TBL] [Abstract][Full Text] [Related]
5. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
[TBL] [Abstract][Full Text] [Related]
6. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
7. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
Rice L; Nguyen PH; Vann AR
Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopaenia.
Prince M; Wenham T
Postgrad Med J; 2018 Aug; 94(1114):453-457. PubMed ID: 30126928
[TBL] [Abstract][Full Text] [Related]
9. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
11. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
Davenport A
Am J Kidney Dis; 1998 Oct; 32(4):E3. PubMed ID: 10074589
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
[TBL] [Abstract][Full Text] [Related]
13. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Warkentin TE
Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.
Napolitano LM; Warkentin TE; Almahameed A; Nasraway SA
Crit Care Med; 2006 Dec; 34(12):2898-911. PubMed ID: 17075368
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
Ranze O; Ranze P; Magnani HN; Greinacher A
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
[TBL] [Abstract][Full Text] [Related]
17. Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia.
Tardy-Poncet B; Combe M; Piot M; Chapelle C; Akrour M; Tardy B
Thromb Haemost; 2013 Mar; 109(3):504-9. PubMed ID: 23328916
[TBL] [Abstract][Full Text] [Related]
18. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
19. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
[TBL] [Abstract][Full Text] [Related]
20. [Heparin-induced thrombocytopenia].
Christoffersen C; Lethagen S; Gøtze JP
Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
